Sprawdź pisownię lub spróbuj wyszukać bardziej ogólnego wyrażenia
Blog LFT jest poświęcony rosnącej roli laserowego usuwania mętów w praktyce klinicznej. Kuratorowany przez Dr. I. Singh’a, MD, który wykonał ponad 3.000 zabiegów laserowego usuwania mętów, blog ten porusza liczne tematy dotyczące terapii pacjentów z objawami mętów. Dr Singh prowadzi swoją prywatną praktykę w The Eye Centers of Racine & Kenosha w Wisconsin, w USA. Był pierwszym okulistą w Wisconsin i w Illinois, który dokonał wszczepienia implantu drenującego iStent w celu leczenia jaskry. Ostatnio pomagał w pionierskich działaniach na rzecz opracowania nowych soczewek i technologii laserowych przeznaczonych do stosowania przy laserowym usuwaniu mętów.
In medicine, our decision to treat or not to treat a condition has been based on the risk-benefit ratio associated with the treatment. Basically, the higher the risk, the worse the symptoms usually have to be before the surgeon and patient are willing to perform the surgery. As technology has advanced, the risk associated with many procedures has generally decreased, subsequently leading to surgeons and patients opting to perform the procedure much earlier in the disease process.Read more
In recent years, there has no doubt been an increased interest in modern laser floater removal, LFR. Within the past five years since I began performing the procedure, more and more surgeons are now adopting LFR in their practices. Although the procedure may seem fairly new, surgeons may not realize that the use of a YAG laser to treat symptomatic floaters has been performed for many decades. So, why is this procedure only now starting to gain traction?Read more
Our cataract patients’ expectations have steadily increased as our surgical technique and IOL technology has advanced over the years. As a profession, we have focused a great deal of attention on the smallest detail during the entire process; pre-op, (including biometry, topography, OCT), to intraoperative tools and techniques (such as femtosecond assisted surgery, intra op aberrometry, and premium IOLs), to postop drop and capsule management.Read more
Historically, as a profession, we have created the perception that vitreous floaters (opacities) are a mere annoyance to our patients. A condition that, although many people complain of, does not cause a significant enough impact on quality of life and daily functioning to warrant treatment. Why is that? Why is it considered just an annoyance when patients often complain of difficulty driving, reading, or even working on a computer?Read more